06/09/2025
3:16 PM | Celldex Therapeutics (Issuer)
PEPIN RONALD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:17 PM | Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:18 PM | Celldex Therapeutics (Issuer)
Jimenez Freddy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:21 PM | Celldex Therapeutics (Issuer)
Heath-Chiozzi Margo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:22 PM | Celldex Therapeutics (Issuer)
Crowley Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:22 PM | Cavanaugh Sarah (Reporting)
Celldex Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:05 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
7:10 AM | Celldex Therapeutics (Issuer)
Torres Denice (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/15/2025
10:48 AM | Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
04/21/2025
7:01 AM | Celldex Therapeutics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for CLDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Celldex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/10/2025
3:05 PM | Celldex Therapeutics (Subject)
COMMODORE CAPITAL LP (Filed by)
| Form SCHEDULE 13G | |
02/27/2025
3:01 PM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:16 PM | Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:44 AM | Celldex Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025
8:28 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/14/2024
6:47 PM | Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
11:18 AM | Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
5:12 AM | Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
5:00 PM | Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
11/12/2024
8:55 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Celldex Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024
4:34 PM | Celldex Therapeutics (Subject)
Crowley Elizabeth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:12 PM | Celldex Therapeutics (Subject)
Martin Samuel Bates (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
7:00 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:05 PM | Celldex Therapeutics (Issuer)
Young Diane C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy CLDX Stock Free CLDX Stock Alerts